Broad plasma protein replacement (null)

Broad plasma protein replacement is a therapeutic approach, not a defined molecular or genetic drug target, involving the infusion of pooled or fractionated plasma proteins. The intervention can support or restore multiple physiological blood functions, including hemostasis, oncotic pressure, immune defense, and specific enzyme activity, in conditions of acute loss, congenital deficiency, or therapeutic removal (such as plasmapheresis). Common clinical contexts include trauma, bleeding disorders, immune deficiencies, and genetic protein/enzyme deficiencies. Commercial agents include plasma protein fraction (human)—mainly albumin and globulins—and other plasma-derived or recombinant protein therapies. This entry is not a valid molecular target, but a therapy describing a class of interventions using mixtures of plasma proteins[8][4][3][9].

Other names

Plasma protein fraction (human)Human plasma proteinHuman plasma proteinsPlasma protein therapyPlasma protein replacement therapy

Direct protein replacement: restores specific proteins (albumin, clotting factors, enzymes) to address deficiency; Volume expansion: maintains blood pressure and tissue perfusion in shock states; Immunomodulation: IVIg, plasma exchange to modulate immune system activity